Bluebird Stock Future Price Prediction

BLUE
 Stock
  

USD 7.59  0.07  0.93%   

Bluebird Bio stock price prediction is an act of determining the future value of Bluebird Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Bluebird Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bluebird Bio and does not consider all of the tangible or intangible factors available from Bluebird Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Bluebird Bio, which may create opportunities for some arbitrage if properly timed.
Continue to Bluebird Bio Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Bluebird Bio based on different types of headlines from major news networks to social media. The Bluebird stock price prediction module provides an analysis of price elasticity to changes in media outlook on Bluebird Bio over a specific investment horizon.
EPS Estimate Next Quarter
(0.45) 
EPS Estimate Current Year
(4.29) 
EPS Estimate Next Year
(2.30) 
Wall Street Target Price
7.33
EPS Estimate Current Quarter
(1.12) 
Quarterly Revenue Growth YOY
(0.93) 
Using Bluebird Bio hype-based prediction, you can estimate the value of Bluebird Bio from the perspective of Bluebird Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bluebird Bio using Bluebird Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bluebird using crowd psychology based on the activity and movement of Bluebird Bio's stock price.
Bluebird Bio PPandE Turnover is projected to slightly decrease based on the last few years of reporting. The past year's PPandE Turnover was at 0.042449. The current year Accounts Payable Turnover is expected to grow to 0.16, whereas Cash Flow Per Share is forecasted to decline to (9.65) .

Bluebird Bio Short Interest

A significant increase or decrease in Bluebird Bio's short interest from the previous month could be a good indicator of investor sentiment towards Bluebird. Short interest can provide insight into the potential direction of Bluebird Bio stock and how bullish or bearish investors feel about the market overall. An investor who is long Bluebird Bio may also wish to track short interest. As short interest increases, investors should be becoming more worried about Bluebird Bio and may potentially protect profits, hedge Bluebird Bio with its derivative instruments, or be ready for some potential downside.
200 Day MA
5.26
Short Percent
0.36
Short Ratio
4.96
Shares Short Prior Month
22.4 M
50 Day MA
6.53
Shares Short
22.5 M

Bluebird Bio Hype to Price Pattern

Investor biases related to Bluebird Bio's public news can be used to forecast risks associated with investment in Bluebird. The trend in average sentiment can be used to explain how an investor holding Bluebird can time the market purely based on public headlines and social activities around Bluebird Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bluebird Bio's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bluebird Bio.

Bluebird Bio Implied Volatility

    
  110.6  
Bluebird Bio's implied volatility exposes the market's sentiment of Bluebird Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bluebird Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bluebird Bio stock will not fluctuate a lot when Bluebird Bio's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Bluebird Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Bluebird Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Bluebird because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bluebird Bio after-hype prediction price

    
  $ 7.16  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bluebird Bio in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
3.7610.2216.68
Details
Naive
Forecast
LowNext ValueHigh
1.177.6314.09
Details
13 Analysts
Consensus
LowTarget PriceHigh
10.0019.9045.00
Details
Earnings
Estimates (5)
LowProjected EPSHigh
-11.68-11.42-11.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bluebird Bio. Your research has to be compared to or analyzed against Bluebird Bio's peers to derive any actionable benefits. When done correctly, Bluebird Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bluebird Bio.

Bluebird Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Bluebird Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bluebird Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bluebird Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bluebird Bio Estimiated After-Hype Price Volatility

In the context of predicting Bluebird Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bluebird Bio's historical news coverage. Bluebird Bio's after-hype downside and upside margins for the prediction period are 0.70 and 13.62, respectively. We have considered Bluebird Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 7.59
7.16
After-hype Price
13.62
Upside
Bluebird Bio is slightly risky asset. Analysis and calculation of next after-hype price of Bluebird Bio is based on 3 months time horizon.

Bluebird Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Bluebird Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bluebird Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bluebird Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.60  6.41   0.42   1.77  6 Events / Month1 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
7.597.165.67 
915.71  

Bluebird Bio Hype Timeline

Bluebird Bio is currently traded for 7.59. The entity has historical hype elasticity of -0.42 and average elasticity to hype of competition of 1.77. Bluebird is anticipated to decline in value after the next headline with the price expected to drop to 7.16. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -5.67% whereas the daily expected return is currently at 0.6%. The volatility of related hype on Bluebird Bio is about 216.92% with expected price after next announcement by competition of 9.36. About 82.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluebird Bio recorded a loss per share of 9.95. The entity had not issued any dividends in recent years. The firm had a split on the 5th of November 2021. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days.
Continue to Bluebird Bio Basic Forecasting Models to cross-verify your projections.

Bluebird Bio Related Hype Analysis

Having access to credible news sources related to Bluebird Bio's direct competition is more important than ever and may enhance your ability to predict Bluebird Bio's future price movements. Getting to know how Bluebird Bio rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bluebird Bio may potentially react to the hype associated with one of its peers.

Bluebird Bio Additional Predictive Modules

Most predictive techniques to examine Bluebird price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bluebird using various technical indicators. When you analyze Bluebird charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bluebird Bio Predictive Indicators

The successful prediction of Bluebird Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bluebird Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bluebird Bio based on analysis of Bluebird Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bluebird Bio's related companies.
 2021 2022 (projected)
PPandE Turnover0.04240.0436
Long Term Debt to Equity0.09350.11

Story Coverage note for Bluebird Bio

The number of cover stories for Bluebird Bio depends on current market conditions and Bluebird Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bluebird Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bluebird Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bluebird Bio Short Properties

Bluebird Bio's future price predictability will typically decrease when Bluebird Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bluebird Bio often depends not only on the future outlook of the potential Bluebird Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluebird Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out29.10%
Short Percent Of Float39.90%
Float Shares66.63M
Shares Short Prior Month20.1M
Average Daily Volume Last 10 Day4.59M
Average Daily Volume In Three Month6.19M
Date Short Interest14th of October 2022
Continue to Bluebird Bio Basic Forecasting Models to cross-verify your projections. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for analysis

When running Bluebird Bio price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
623.5 M
Quarterly Revenue Growth YOY
(0.93) 
Return On Assets
(0.29) 
Return On Equity
(0.84) 
The market value of Bluebird Bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Bluebird Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.